Clolar FDA Approval History
FDA Approved: Yes (First approved December 28, 2004)
Brand name: Clolar
Generic name: clofarabine
Dosage form: for Intravenous Infusion
Company: Genzyme Corp.
Treatment for: Acute Lymphoblastic Leukemia
Clolar (clofarabine) is a purine nucleoside anti-metabolite indicated for the treatment of children with refractory or relapsed acute lymphoblastic leukemia (ALL).
Development Timeline for Clolar
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.